Xiaojie Tan
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- NF-κB Signaling Pathways
- MicroRNA in disease regulation
Papers in
-
- Hepatitis C virus research 6
-
- Cancer Genomics and Diagnostics 5
- NF-κB Signaling Pathways 4
Xiaojie Tan
70 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 135
- Hepatology 250
- Cancer Research 411
- Oncology 352
- Molecular Biology 754
- Epidemiology 329
Countries citing papers authored by Xiaojie Tan
This map shows the geographic impact of Xiaojie Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojie Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojie Tan more than expected).
Fields of papers citing papers by Xiaojie Tan
This network shows the impact of papers produced by Xiaojie Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojie Tan. The network helps show where Xiaojie Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaojie Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 26 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 30 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 62 | |
| 12 | 2021 | 13 | |
| 13 | 2019 | 24 | |
| 14 | 2013 | 9 | |
| 15 | 2011 | 27 | |
| 16 | RESEARCH AND ADVANCES IN MARINE GEO-HAZARDS | 2011 | 1 |
| 17 | 2010 | 57 | |
| 18 | 2010 | 80 | |
| 19 | 2010 | 8 | |
| 20 | 2008 | 61 |
About Xiaojie Tan
Xiaojie Tan is a scholar working on Hepatology, Cancer Research, Acoustics and Ultrasonics, Oncology and Instrumentation, having authored 74 papers that have together received 1.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (12 papers), Hepatitis B Virus Studies (8 papers), Hepatitis C virus research (6 papers), Renal and related cancers (6 papers), Colorectal Cancer Surgical Treatments (5 papers), Cancer Genomics and Diagnostics (5 papers), Gastric Cancer Management and Outcomes (5 papers) and NF-κB Signaling Pathways (4 papers). The work is most often cited by research in Hepatology (250 citations), Cancer Research (411 citations), Oncology (352 citations), Molecular Biology (754 citations) and Epidemiology (329 citations). Xiaojie Tan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Guangwen Cao, Wenjun Chang, Jianhua Yin, Yongwei Yu, Yibo Ding, Tong Su, Liye Ma, Jianguo Hou, Yan Du and Hongwei Zhang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, Oncotarget, International Journal of Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.